First Tracks Biotherapeutics, Inc. (TRAX)
Healthcare
Biotechnology
—
44.00 $
-7.8%
vs. previous close
Closing price · As of: 31. Jul 2026
First Tracks Biotherapeutics, Inc. (TRAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -143 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | 2023 | 2024 | 2025 |
|---|---|---|---|
| -93 | -126 | -143 | |
| 2.4 | 2.4 | 2.4 | |
| 18 | 27 | 32 | |
| 2.9 | 19 | -1.5 | |
| 0.8 | 0.4 | 0.1 | |
| 145 | 95 | 228 | |
| -87 | 118 | 30 | |
| -35 | 87 | 115 | |
| -94 | -126 | -143 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.